期刊
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
卷 20, 期 12, 页码 1036-1046出版社
OXFORD UNIV PRESS
DOI: 10.1093/ijnp/pyx056
关键词
dopamine; depression; hippocampus; amygdala; ketamine; animal models
资金
- United States Public Health Service [MH191180]
- Agence Nationale de la Recherche [ANR-15-CE37-0010]
- Agence Nationale de la Recherche (ANR) [ANR-15-CE37-0010] Funding Source: Agence Nationale de la Recherche (ANR)
Anhedonia is considered a core feature of major depressive disorder, and the dopamine system plays a pivotal role in the hedonic deficits described in this disorder. Dopaminergic activity is complex and under the regulation of multiple brain structures, including the ventral subiculum of the hippocampus and the basolateral amygdala. Whereas basic and clinical studies demonstrate deficits of the dopaminergic system in depression, the origin of these deficits likely lies in dysregulation of its regulatory afferent circuits. This review explores the current information regarding the afferent modulation of the dopaminergic system and its relevance to major depressive disorder, as well as some of the system-level effects of novel antidepressants such as agomelatine and ketamine.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据